摘要
The applications of modem artificial intelligence (AI) algorithms within the field of aging research offer tremendous opportunities. Aging is an almost universal unifying feature possessed by all living organisms, tissues, and cells. Modem deep learning techniques used to develop age predictors offer new possibilities for formerly incompatible dynamic and static data types. AI biomarkers of aging enable a holistic view of biological processes and allow for novel methods for building causal models-extracting the most important features and identifying biological targets and mechanisms. Recent developments in generative adversarial networks (GANs) and reinforcement learning (RL) permit the generation of diverse synthetic molecular and patient data, identification of novel biological targets, and generation of novel molecular compounds with desired properties and geroprotectors. These novel techniques can be combined into a unified, seamless end-to-end biomarker development, target identification, drug discovery and real world evidence pipeline that may help accelerate and improve pharmaceutical research and development practices. Modem AI is therefore expected to contribute to the credibility and prominence of longevity biotechnology in the healthcare and pharmaceutical industry, and to the convergence of countless areas of research.
学科与关键词
- Deep biomarkers of aging and longevity: from research to applicationsZhavoronkov, Alex*; Li, Ricky; Ma, Candice; Mamoshina, PolinaAging-US, 2019, 11(22): 10771-10780.被引 35
- Validation requirements for AI-based intervention-evaluation in aging and longevity research and practiceFuellen, Georg*; Kulaga, Anton; Lobentanzer, Sebastian; Unfried, Maximilian; Avelar, Roberto A.; Palmer, Daniel; Kennedy, Brian K.*AGEING RESEARCH REVIEWS, 2025, 104: 102617.
- Artificial intelligence for the study of human ageing: a systematic literature reviewBernal, Mary Carlota; Batista, Edgar*; Martinez-Balleste, Antoni; Solanas, AgustiApplied Intelligence, 2024, 54(22): 11949-11977.
